S
Steve Colley
Researcher at Queen Elizabeth Hospital Birmingham
Publications - 11
Citations - 1186
Steve Colley is an academic researcher from Queen Elizabeth Hospital Birmingham. The author has contributed to research in topics: Magnetic resonance imaging & Positron emission tomography. The author has an hindex of 6, co-authored 11 publications receiving 947 citations.
Papers
More filters
Journal ArticleDOI
Guidelines for the management of thyroid cancer
Petros Perros,Kristien Boelaert,Steve Colley,Carol Evans,Rhordi M Evans,Georgina Gerrard Ba,Jackie Gilbert,Barney Harrison,Sarah J. Johnson,T. Giles,Laura Moss,Val Lewington,Kate Newbold,Judith Taylor,Rajesh V. Thakker,John Watkinson,Graham R. Williams +16 more
Journal ArticleDOI
Diffusion-weighted magnetic resonance imaging for residual and recurrent cholesteatoma: a systematic review and meta-analysis.
TL;DR: Diagnosis and management of recurrent or residual cholesteatoma can be problematic and diffusion‐weighted imaging magnetic resonance imaging (MRI) sequences have been used for follow‐up of such lesions.
Journal ArticleDOI
Cone beam CT paranasal sinuses versus standard multidetector and low dose multidetector CT studies.
TL;DR: Cone beam CT scan provides a fast and efficient alternative to conventional CT with substantial radiation dose reduction and low dose MDCT techniques, however for more advanced sinus disease, conventional CT scan is preferable.
Journal ArticleDOI
Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neck
Paweł Golusiński,Pasquale Di Maio,Berrin Pehlivan,Steve Colley,Paul Nankivell,Anthony Kong,Andrew Hartley,Hisham Mehanna +7 more
TL;DR: A new, evidence-based protocol is presented that aims to identify the site of the primary tumor, and determine the stage of the disease, including extranodal extension, and thereby potentially minimise toxicity and improving functional outcomes.
Journal ArticleDOI
The role of positron emission tomography/CT imaging in head and neck cancer patients after radical chemoradiotherapy
TL;DR: Patients with a negative PET/CT scan after radical chemoradiotherapy have a 91.8% chance of remaining free of local recurrence 19 months post-treatment, which may aid subsequent management decisions.